Latest information on COVID-19

About Us

"Welcome to Stanford Vascular and Endovascular Surgery. We are dedicated to the highest levels of patient care, professional education, and clinical and translational research."

Ronald L. Dalman, MD
Chidester Professor
and Division Chief of Vascular Surgery


The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.

The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.

Heart Health

"Good vascular health is the key to longevity"

Watch Elsie Ross, MD Vascular Surgeon and Eri Fukaya, MD Vascular Medicine Specialist, discuss the importance of vascular health and how to protect your vascular system.
Learn more with Stanford Health Care Heart Health Month

Stanford Hospital, 500P

November 17, 2019


Watch the new Stanford Hospital Dedication

See aerial views of the new Stanford Hospital

News & Events

Promotion to Clinical Professor

We are excited to annonce that Dr. Manuel Garcia-Toca has been promoted to Clinical Professor of Surgery, effective November 1, 2020.  We congratulate Dr. Garcia-Toca on this accomplishment and thank him for his didication to our division.  We will continue to look forward to future achievements.  

Metformin Abdominal Aortic Aneurysm Suppression Trial

Dr. Dalman's publication in the Vascular & Endovascular Review outlines the background and proposed design for his study on metformin for growth suppression in patients with small AAA.

Dr. Dalman recently received an NIH R61-33 grant to fund his Limiting AAA with Metformin (LIMIT Trial). The trial will study Metformin Abdominal Aortic Aneurysm Suppression.  Patients will be enrolled starting Summer 2021. 

Link to publication in VER

Dr. Arya to Chair AVAS Diversity and Inclusion Committee

Dr. Shipra Arya has been chosen to chair the Association of VA Surgeons' (AVAS) new Diversity and Inclusion Committee.


OUR PROGRAMS

Patient Care

We provide expert care for patients with complex aortic, arterial and venous disorders.

 

OUR PROGRAMS

Education

ACGME-accredited Stanford Traditional Vascular Residency (5+2 yrs)

ACGME-accredited Stanford Integrated Vascular Residency (0+5 yrs)

Vascular Medicine Fellowship

Interesting Cases

Educational Seminars

Research

Basic, translational and applied research into all facets of vascular disease.